Dr. Gulam Manji presented results from a phase II clinical trial testing a combination therapy for resectable gastric cancer or gastroesophageal junction (GEJ) cancer at this year’s AACR conference.
In Notes from the Lab, we spotlight the Giancotti lab and new research identifying factors that sustain prostate cancer cells that have become resistant to androgen receptor (AR) therapy.
A new instrument at Columbia will help scientists uncover the full potential of heavy ion radiation therapy and could improve treatment of pancreatic cancer and other difficult-to-treat tumors.
Researchers have developed a “cloaking” system that temporarily hides therapeutic bacteria from immune systems, enabling them to more effectively deliver drugs to tumors and kill cancer cells.
Columbia University researchers uncovered a signaling pathway in EGFR-mutant lung cancer responsible for driving recurrence and metastases, spreading to the brain.
The Trainee Associate Member Pilot Grants Program aims to support up-and-coming graduate and medical student and post-graduate researchers across Columbia working on all aspects of cancer research.
To stop acute myeloid leukemia, targeting neighboring bone cells may be a better strategy than directly targeting the cells that drive the cancer, suggests a new study led by Stavroula Kousteni, PhD.
Researchers from the Herbert Irving Comprehensive Cancer Center presented new research on breast cancer risk prediction at the 2021 San Antonio Breast Cancer Symposium.
Congratulations to HICCC members named as 2021 Highly Cited Researchers--researchers who produced multiple papers ranking in the top 1% globally by citations for their field and year of publication.